Started in 2008, MeilunBio® provides life science scientists and biopharmaceutical companies around the world with international standard research tools, materials and technical services based on a state-of-the-art R&D platform and a rigorous quality management system.
MeilunBio® has established six major technology platforms: molecular biology, cell biology, prokaryotic and eukaryotic protein expression and purification, protein detection, animal experiments and chemical organic synthesis. It has independently developed and produced 800+ products , widely serving basic research in life sciences, basic medical research, drug R&D, cell and gene therapy, in vitro diagnostics (IVD) and other fields. MeilunBio® is looking forward to working hand in hand with scientists around the world to explore the beauty of biology！
10,000+
Citations in Scientific Journals
5,000+
Universities, research institutes and biopharmaceutical companies cooperated
~20,000 m2
R&D platforms
ISO 9001 & ISO 13485
Certified quality management system and production system compliant with cGMP standards
Company virtual
Office Area: The new R&D office area is about 500m2, which consists of Genetic Engineering Project Group, Cell Biology Project Group, Immunology Project Group…
Technology Platform
MeilunBio currently has its own R&D team of more than 100 people led by the PhDs from the Chinese Academy of Sciences, with more than 80% of them having a master‘s degree…
Quality control
Meilunbio® has set up an independent quality control department, and at the same time, it has cooperated with a number of authoritative third-party testing organizations for…